A SWANSEA company at the forefront of laser technology to cure acne has signed a manufacturing agreement with electronics firm BreconRidge.
Enfis, based at the Swansea Tech-nium, has signed a joint development, manufacturing and marketing partner-ship agreement with BreconRidge, which has its European headquarters in Caldicot, Monmouthshire.
The move is a clear sign that Enfis is close to starting commercial production of its technology.
Both companies are focused on developing and utilising best-in-class technologies in product design and in the manufacturing processes.
Enfis was formed in May 2001 as a spin-off from the University of Wales, Swansea. It received funding from Wesley Clover, the Newport-based venture capital fund owned by Wales's most successful entrepreneur, Sir Terry Matthews.
Enfis specialises in developing semi-conductor-based light-source modules and systems. These systems are initially designed for use in the healthcare market, although other complementary markets are also being explored, such as the rapidly-growing displays and industrial sectors.
BreconRidge is a global provider of electronic manufacturing services, as well as consultancy in electronics design, test and manufacture.
Graham Neathway, chairman of BreconRidge said, "We are very excited about this agreement with Enfis. The combination of BreconRidge's global electronics manufacturing and design in conjunction with Enfis's innovative products is a winning proposition to take to market."
The agreement provides Enfis with access to the worldwide ISO9000 certified, design and manufacturing expertise of BreconRidge and provides BreconRidge with a first step into the significant US-based healthcare market and access to Enfis's innovative photonics product team and intellectual property base. The agreement also endorses the BreconRidge's decision to focus on the embryonic semiconductor light source market and to work with strategic customers in this field.
The chief executive of Enfis, Shaun Oxenham, said, "This agreement is a major development in helping us to get our patented technologies to market in the most professional and competitive way."